Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis

Bibliographic Details
Title: Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis
Authors: Qinyi Su, Xinmiao Wang, Yongzhi Li, Jiexiang Zhang, Cairui Bai, Xuechun Wang, Liu Yang, Jingting Zhang, Sheng-Xiao Zhang
Source: Rheumatology and Therapy, Vol 11, Iss 1, Pp 79-96 (2023)
Publisher Information: Adis, Springer Healthcare, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the musculoskeletal system
Subject Terms: Autoimmune rheumatic diseases, Tregs, Meta-analysis, Systematic review, Low-dose Interleukin-2 (LD-IL-2), Diseases of the musculoskeletal system, RC925-935
More Details: Abstract Introduction Current therapies for autoimmune rheumatic diseases (ARDs) have limited efficacy in certain patients, highlighting the need for the development of novel treatment approaches. This meta-analysis aims to assess the efficacy and safety of low-dose interleukin-2 (LD-IL-2) and evaluate the alterations in lymphocyte subsets in various rheumatic diseases following administration of different dosages of LD-IL-2. Methods A comprehensive search was conducted in PubMed, Web of Science, the Cochrane Library, Embase databases and CNKI to identify relevant studies. A total of 31 trials were included in this meta-analysis. The review protocols were registered on PROSPERO (CRD42022318916), and the study followed the PRISMA guidelines. Results Following LD-IL-2 treatment, patients with ARDs exhibited a significant increase in the number of Th17 cells and Tregs compared to their pre-treatment levels [standardized mean difference (SMD) = 0.50, 95% confidence interval (CI) (0.33, 0.67), P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2198-6576
2198-6584
Relation: https://doaj.org/toc/2198-6576; https://doaj.org/toc/2198-6584
DOI: 10.1007/s40744-023-00620-7
Access URL: https://doaj.org/article/8a2656f8856a4b98a505f8a85ce540c7
Accession Number: edsdoj.8a2656f8856a4b98a505f8a85ce540c7
Database: Directory of Open Access Journals
More Details
ISSN:21986576
21986584
DOI:10.1007/s40744-023-00620-7
Published in:Rheumatology and Therapy
Language:English